Correspondence 0001193125-25-065285 from Vor Biopharma Inc. (VOR)
Vor Biopharma Inc.
Date: March 27, 2025 · CIK: 0001817229 · Accession: 0001193125-25-065285
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Vor Biopharma Inc. Registration Statement on Form S-3 (File No. 333- 285969) Request for Acceleration of Effective Date Requested Date: March 31, 2025 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333- 285969) (the “ Registration Statement ”) to become effective on March 31, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Divakar Gupta at (212) 479-6474.
V OR B IOPHARMA I NC . 100 Cambridgepark Drive, Suite 101 Cambridge, MA 02140 March 27, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Lauren Hamill
Very truly yours,
Vor Biopharma Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP V OR B IOPHARMA I NC . 100 Cambridgepark Drive, Suite 101 Cambridge, MA 02140 March 27, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Lauren Hamill Re: Vor Biopharma Inc. Registration Statement on Form S-3 (File No. 333- 285969) Request for Acceleration of Effective Date Requested Date: March 31, 2025 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333- 285969) (the “ Registration Statement ”) to become effective on March 31, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Divakar Gupta at (212) 479-6474. Very truly yours, Vor Biopharma Inc. By: /s/ Robert Ang Robert Ang Chief Executive Officer